Ann Greer

1.5k total citations
20 papers, 832 citations indexed

About

Ann Greer is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Ann Greer has authored 20 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Cancer Research. Recurrent topics in Ann Greer's work include Growth Hormone and Insulin-like Growth Factors (13 papers), Metabolism, Diabetes, and Cancer (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Ann Greer is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (13 papers), Metabolism, Diabetes, and Cancer (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Ann Greer collaborates with scholars based in United States, Canada and Germany. Ann Greer's co-authors include Joan M. Carboni, Marco M. Gottardis, Warren Hurlburt, Ricardo M. Attar, Fei Huang, Karen A. Reeves, Mark D. Wittman, Stephen Hillerman, Zohreh Tabaeizadeh and Dolatrai M. Vyas and has published in prestigious journals such as PLANT PHYSIOLOGY, Cancer Research and European Journal of Biochemistry.

In The Last Decade

Ann Greer

20 papers receiving 810 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ann Greer United States	15	516	298	198	181	133	20	832
Zeenath Jehan Saudi Arabia	17	731 1.4×	180 0.6×	390 2.0×	286 1.6×	176 1.3×	26	1.2k
Shannon C. Dixon United States	14	452 0.9×	56 0.2×	216 1.1×	152 0.8×	222 1.7×	18	844
Robin L. Goode United States	14	396 0.8×	155 0.5×	159 0.8×	101 0.6×	185 1.4×	25	897
Zuyao Ni Canada	18	814 1.6×	58 0.2×	411 2.1×	197 1.1×	122 0.9×	24	1.3k
Giuditta Cuccuru Italy	11	265 0.5×	120 0.4×	185 0.9×	68 0.4×	47 0.4×	17	502
Magdalena Carlberg Sweden	17	372 0.7×	62 0.2×	88 0.4×	134 0.7×	44 0.3×	23	898
Thomas H. Beckham United States	16	503 1.0×	34 0.1×	143 0.7×	74 0.4×	84 0.6×	44	758
Catherine Jones United States	9	203 0.4×	50 0.2×	263 1.3×	203 1.1×	95 0.7×	15	702
Johannes Bange Germany	10	966 1.9×	51 0.2×	420 2.1×	211 1.2×	140 1.1×	17	1.4k
Paula Kaplan‐Lefko United States	13	620 1.2×	99 0.3×	557 2.8×	208 1.1×	345 2.6×	26	1.3k

Countries citing papers authored by Ann Greer

Since Specialization

Citations

This map shows the geographic impact of Ann Greer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Greer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Greer more than expected).

Fields of papers citing papers by Ann Greer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Greer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Greer. The network helps show where Ann Greer may publish in the future.

Co-authorship network of co-authors of Ann Greer

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Greer. A scholar is included among the top collaborators of Ann Greer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Greer. Ann Greer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Fei, Chang Han, Ann Greer, et al.. (2014). IRS2 Copy Number Gain, KRAS and BRAF Mutation Status as Predictive Biomarkers for Response to the IGF-1R/IR Inhibitor BMS-754807 in Colorectal Cancer Cell Lines. Molecular Cancer Therapeutics. 14(2). 620–630. 25 indexed citations

Hou, Xiaonan, Fei Huang, Luciana F. Macedo, et al.. (2011). Dual IGF-1R/InsR Inhibitor BMS-754807 Synergizes with Hormonal Agents in Treatment of Estrogen-Dependent Breast Cancer. Cancer Research. 71(24). 7597–7607. 63 indexed citations

Huang, Fei, Warren Hurlburt, Ann Greer, et al.. (2010). Differential Mechanisms of Acquired Resistance to Insulin-like Growth Factor-I Receptor Antibody Therapy or to a Small-Molecule Inhibitor, BMS-754807, in a Human Rhabdomyosarcoma Model. Cancer Research. 70(18). 7221–7231. 97 indexed citations

Velaparthi, Upender, Mark G. Saulnier, Mark D. Wittman, et al.. (2010). Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors: SAR of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-one. Bioorganic & Medicinal Chemistry Letters. 20(10). 3182–3185. 16 indexed citations

Wittman, Mark D., Joan M. Carboni, ChiehYing Chang, et al.. (2010). Proline isosteres in a series of 2,4-disubstituted pyrrolo[1,2-f][1,2,4]triazine inhibitors of IGF-1R kinase and IR kinase. Bioorganic & Medicinal Chemistry Letters. 20(17). 5027–5030. 16 indexed citations

Hillerman, Stephen, Ann Greer, Warren Hurlburt, et al.. (2010). Abstract 363: Therapeutic targeting of insulin receptor-A with a dual IGF-1R/IR inhibitor: Overcoming a potential escape mechanism from IGF-1R-specific signaling inhibition in insulin receptor-A transfected cancer cells. Cancer Research. 70(8_Supplement). 363–363. 1 indexed citations

Carboni, Joan M., Mark D. Wittman, Zheng Yang, et al.. (2009). BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR. Molecular Cancer Therapeutics. 8(12). 3341–3349. 218 indexed citations

Haluska, Paul, Xinwei Hou, Fei Huang, et al.. (2009). Complete IGF Signaling Blockade by the Dual-Kinase Inhibitor, BMS-754807, Is Sufficient To Overcome Tamoxifen and Letrozole Resistance In Vitro and In Vivo.. Cancer Research. 69(24_Supplement). 402–402. 8 indexed citations

Huang, Fei, Ann Greer, Warren Hurlburt, et al.. (2008). The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors. Cancer Research. 69(1). 161–170. 137 indexed citations

10.

Saulnier, Mark G., David B. Frennesson, Mark D. Wittman, et al.. (2008). 2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924. Bioorganic & Medicinal Chemistry Letters. 18(5). 1702–1707. 20 indexed citations

11.

Zimmermann, Kurt, Mark D. Wittman, Mark G. Saulnier, et al.. (2008). Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(14). 4075–4080. 17 indexed citations

12.

Velaparthi, Upender, Mark D. Wittman, Peiying Liu, et al.. (2007). Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R). Bioorganic & Medicinal Chemistry Letters. 17(8). 2317–2321. 35 indexed citations

13.

Velaparthi, Upender, Peiying Liu, Balu Balasubramanian, et al.. (2007). Imidazole moiety replacements in the 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one inhibitors of insulin-like growth factor receptor-1 (IGF-1R) to improve cytochrome P450 profile. Bioorganic & Medicinal Chemistry Letters. 17(11). 3072–3076. 34 indexed citations

14.

Wittman, Mark D., Balu Balasubramanian, Upender Velaparthi, et al.. (2006). Novel 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase. Bioorganic & Medicinal Chemistry Letters. 17(4). 974–977. 19 indexed citations

15.

Chen, Ridong, Ann Greer, & Antony M. Dean. (1997). Structural Constraints in Protein Engineering. European Journal of Biochemistry. 250(2). 578–582. 19 indexed citations

16.

Greer, Ann, et al.. (1997). Use of Mixtures of Allelochemicals to Compare Bioassays Using Red Maple, Pin Cherry, and American Elm. Journal of Chemical Ecology. 23(4). 1101–1117. 10 indexed citations

17.

Agharbaoui, Zahra, Ann Greer, & Zohreh Tabaeizadeh. (1995). Transformation of the wild tomatoLycopersicon chilense Dun. byAgrobacterium tumefaciens. Plant Cell Reports. 15(1-2). 102–105. 14 indexed citations

18.

Greer, Ann, et al.. (1994). Isolation of an osmotic stress- and abscisic acid-induced gene encoding an acidic endochitinase from Lycopersicon chilense. Molecular and General Genetics MGG. 245(2). 195–202. 55 indexed citations

19.

Greer, Ann, et al.. (1993). Sequence of a Novel Abscisic Acid- and Drought-Induced cDNA from Wild Tomato (Lycopersicon chilense). PLANT PHYSIOLOGY. 103(1). 301–301. 22 indexed citations

20.

Greer, Ann & Zohreh Tabaeizadeh. (1991). Characterization and plant regeneration of cell suspension cultures of Lycopersicon chilense. Canadian Journal of Botany. 69(10). 2257–2260. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact